Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.07
+0.04 (0.40%)
At close: Sep 1, 2026, 4:00 PM EDT
9.96
-0.11 (-1.09%)
Pre-market: Sep 2, 2026, 8:08 AM EDT
Haleon Market Cap
Haleon has a market cap or net worth of $44.08 billion as of September 2, 2026. Its market cap has increased by 0.39% in one year.
Market Cap
44.08B
Enterprise Value
54.21B
1-Year Change
0.39%
Ranking
Category
Stock Price
$10.07
ChartMarket Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $44.08B, an increase of 29.10%. That is a compound annual growth rate of 6.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 44.08B | -1.89% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 58.30B |
| Teva Pharmaceutical Industries | 42.17B |
| Zoetis | 31.92B |
| United Therapeutics | 21.99B |
| Viatris | 19.10B |
| Neurocrine Biosciences | 15.93B |
| Elanco Animal Health | 11.95B |
| Dr. Reddy's Laboratories | 10.28B |